Table 7.
Cancer Type | Cancers | Expression of HDAC6-Comments | References |
---|---|---|---|
Solid tumors | Bladder | Overexpressed | [113] |
Melanoma | Overexpressed | [113] | |
Lung | Overexpressed | [113] | |
Oral squamous cell carcinoma | Overexpressed-Enhanced expression in advanced stages | [68,114] | |
Ovarian carcinoma | Overexpressed-Enhanced expression in advanced stages | [68,114] | |
Breast | Overexpressed-Prediction of a good or bad prognosis | [68,115] | |
Hepatocytic carcinoma | Overexpressed-Enhanced expression in advanced stages | [68] | |
Under-expressed-HDAC6 suggested as a tumor suppressor | [68,116] | ||
Hematological | Chronic lymphocytic leukemia | Overexpressed-Observation on patient samples, cell lines and a transgenic mouse model | [114] |
Acute myeloid leukemia | Overexpressed | [68,114] | |
Acute lymphoblastic leukemia | Overexpressed-Enhanced expression in advanced stages | [68] | |
Chronic lymphocytic leukemia | Overexpressed-Correlated with longer survival | [68] | |
T-cell cutaneous lymphoma | Overexpressed-Correlated with longer survival | [68] | |
Chronic myeloid leukemia | Overexpressed-Increased expression in CD34+ cells | [117] | |
Multiple myeloma | Overexpressed | [118] | |
Mantle cell lymphoma | Overexpressed | [118] | |
Diffuse large B cell lymphoma | Overexpressed | [118] | |
Peripheral T-cell lymphoma | Overexpressed | [118] |
CD: cluster of differentiation; HDAC6: histone deacetylase 6.